Wir möchten auf unserer Internetseite Dienste von Drittanbietern nutzen, die uns helfen, unsere Werbeangebote zu verbessern (Marketing), die Nutzungsweise unserer Internetseite auszuwerten (Performance) und die Internetseite an Ihre Vorlieben anzupassen (Funktional). Für den Einsatz dieser Dienste benötigen wir Ihre Einwilligung, welche jederzeit widerrufen werden kann. Informationen zu den Diensten und eine Widerspruchsmöglichkeit finden Sie unter „Benutzerdefiniert“. Weitergehende Informationen finden Sie in unserer Datenschutzerklärung.
Lyogistics Zero: an innovative freeze dryer vial automatic loading/unloading system with the ability to have CIP/SIP inside chamber
Breakthrough innovations in Freeze Drying
Lyogistics Zero is the only vial automatic loading & unloading system for freeze-drying processes which can be cleaned (CIP) and sterilized (SIP) in place, inside the freeze-dryer chamber.
Developed by Telstar, Lyogistics Zero leads to a new generation automatic vial loading & unloading system for GMP freeze-dryers integrating a steam-sterilizable slider with no concealed parts which is moved by a contact-free magnetic drive mechanism. This innovative system enables the transfer device, or ‘slider’, to remain inside the chamber to undergo cleaning and sterilization in place along with the internals of the freeze dryer.
The absence of mechanical links between the drive and the slider provides the system with unprecedented levels of precision and robustness. Without belts, bellows or racks, the new loading/unloading system slides smoothly and unhindered to maintain integrity of the freeze-drying process and product under fully aseptic conditions. Suitable for use in production processes involving hazardous products, Lyogistics Zero has been designed to be integrated within aseptic isolators requiring high level of protection for the operator (OEL5), the product (ISO5) and the environment.
Leider gibt es für diesen Aussteller kein deutsches Firmenprofil.
Telstar is a company that develops high-technology solutions in engineering, construction, process equipment, and services for the life sciences market, including the pharmaceutical and biotechnological industries, hospitals, laboratories, and research centres.
Recognised as one of the global major suppliers for the pharmaceutical industry, the company also provides global services to turnkey projects and critical installations.
Telstar is one of the few international manufacturers who are able to offer integrated process solutions for the biopharmaceutical industry, with in-house sterilisation, freeze-drying, aseptic and containment barrier Isolators, generation of water and pure steam, as well as clean air technologies. Telstar invests 3% of its turnover in research, development, and innovation of its technologies and equipment.
Telstar specialises in the application of in-house technologies to design and develop integrated process solutions, which are implemented in existing facilities or new pharmaceutical and biotechnological plants, as well as new research laboratories.
Telstar provides high added-value solutions in consultancy, engineering, and construction of pharmaceutical and biotechnology plants, as well as complete laboratories for the manufacture of medicines, including critical equipment.
This encompasses validation, regulatory compliance, and implementation services for logistics management and maintenance systems. Telstar takes on overall management of customised, integrated, innovative and effective turnkey projects, including consultancy, development, and end-to-end monitoring of projects.
The company designs integrated turnkey projects, from the technical feasibility study and definition requirements, development of basic and detailed engineering using the most advanced tools to ensure a top-quality result from the start of a project, right through to qualification.
All activities are overseen by a project management team of Telstar professionals who works closely with the client to offer support and advice in critical decision-making, as well as ensuring the success of the project.
Telstar focuses on strategic technology-based businesses and services aimed at addressing regulatory compliance requirements in critical manufacturing processes in the life sciences sector, ensuring efficiency, quality, and risk minimisation. At the same time, the company also provides compliance with quality regulations and standards demanded by different national and international health authorities.
In this area, Telstar supports companies to help them comply with quality standards in research and development (R&D), clinical trials, registration, and industrial and pharmacovigilance throughout a products’ lifecycle.
As a subsidiary of Azbil, Telstar leads the life science engineering business division of the Japanese corporation to provide global solutions in design, engineering, and manufacturing processes, with automation technologies for international markets such as biopharmaceutical, research, personalised medicine, regenerative medicine, and foods.
Telstar operates in more than 100 countries and has five production plants, seven technology centres, and 13 consulting and engineering services centres, with commercial offices worldwide. It has manufacturing plants in Spain, China, and the UK. Headquartered in Terrassa (Barcelona, Spain), it has a workforce of 900.